0001104659-24-108375.txt : 20241015 0001104659-24-108375.hdr.sgml : 20241015 20241015083101 ACCESSION NUMBER: 0001104659-24-108375 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241010 FILED AS OF DATE: 20241015 DATE AS OF CHANGE: 20241015 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gilad Oren CENTRAL INDEX KEY: 0001929300 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 241369442 MAIL ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aprea Therapeutics, Inc. CENTRAL INDEX KEY: 0001781983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 BUSINESS PHONE: 617-463-9385 MAIL ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 4 1 tm2426059-3_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-10-10 0 0001781983 Aprea Therapeutics, Inc. APRE 0001929300 Gilad Oren 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 1 1 0 0 President/CEO 0 Common Stock 2024-10-10 4 P 0 150 2.54 A 331645 D Common Stock 2024-10-14 4 P 0 1000 2.59 A 332645 D Common Stock 1200 I By Daughter Common Stock 600 I By Son The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. /s/ John Hamill, as Attorney-in-Fact 2024-10-15